ID: ALA4781327

Max Phase: Preclinical

Molecular Formula: C16H25NO2

Molecular Weight: 263.38

Molecule Type: Unknown

Associated Items:

Representations

Canonical SMILES:  NCCC(O)c1cccc(OCC2CCCCC2)c1

Standard InChI:  InChI=1S/C16H25NO2/c17-10-9-16(18)14-7-4-8-15(11-14)19-12-13-5-2-1-3-6-13/h4,7-8,11,13,16,18H,1-3,5-6,9-10,12,17H2

Standard InChI Key:  WJIGGYYSZBWCGC-UHFFFAOYSA-N

Associated Targets(non-human)

Retinoid isomerohydrolase 75 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 263.38Molecular Weight (Monoisotopic): 263.1885AlogP: 3.03#Rotatable Bonds: 6
Polar Surface Area: 55.48Molecular Species: BASEHBA: 3HBD: 2
#RO5 Violations: 0HBA (Lipinski): 3HBD (Lipinski): 3#RO5 Violations (Lipinski): 0
CX Acidic pKa: CX Basic pKa: 9.67CX LogP: 2.49CX LogD: 0.28
Aromatic Rings: 1Heavy Atoms: 19QED Weighted: 0.83Np Likeness Score: -0.18

References

1. Blum E,Zhang J,Korshin E,Palczewski K,Gruzman A.  (2020)  Development of chiral fluorinated alkyl derivatives of emixustat as drug candidates for the treatment of retinal degenerative diseases.,  30  (18.0): [PMID:32717613] [10.1016/j.bmcl.2020.127421]
2. Blum E, Zhang J, Zaluski J, Einstein DE, Korshin EE, Kubas A, Gruzman A, Tochtrop GP, Kiser PD, Palczewski K..  (2021)  Rational Alteration of Pharmacokinetics of Chiral Fluorinated and Deuterated Derivatives of Emixustat for Retinal Therapy.,  64  (12.0): [PMID:34081480] [10.1021/acs.jmedchem.1c00279]

Source